Zoltan Kerekes - Net Worth and Insider Trading
Zoltan Kerekes Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Zoltan Kerekes owns 2 companies in total, including Ibere Pharmaceuticals (IBER.U) , and Ibere Pharmaceuticals (IBER) .
Click here to see the complete history of Zoltan Kerekes’s form 4 insider trades.
Insider Ownership Summary of Zoltan Kerekes
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| IBER.U | Ibere Pharmaceuticals | 2021-02-25 | director & 10 percent owner & Chief Operating Officer |
| IBER | Ibere Pharmaceuticals | 2021-02-25 | director & 10 percent owner & Chief Operating Officer |
Zoltan Kerekes Trading Performance
Zoltan Kerekes Ownership Network
Zoltan Kerekes Owned Company Details
What does Ibere Pharmaceuticals do?
Who are the key executives at Ibere Pharmaceuticals?
Zoltan Kerekes is the director & 10 percent owner & Chief Operating Officer of Ibere Pharmaceuticals. Other key executives at Ibere Pharmaceuticals include director & 10 percent owner & Chief Executive Officer Osagie O Imasogie , director & 10 percent owner & Chief Financial Officer Lisa M. Gray , and 10 percent owner Pipv Capital Llc .
Ibere Pharmaceuticals (IBER.U) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Ibere Pharmaceuticals (IBER.U) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ibere Pharmaceuticals (IBER.U) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Ibere Pharmaceuticals (IBER.U)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ibere Pharmaceuticals Insider Transactions
Zoltan Kerekes Mailing Address
Above is the net worth, insider trading, and ownership report for Zoltan Kerekes. You might contact Zoltan Kerekes via mailing address: 2005 Market Street, Suite 2030, Philadelphia Pa 19103.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
